Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 1,736 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: work therapy Clear all

Conditions: Vital Signs
Interventions: KAP Survey; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 23 Years to 100 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Hyperglycemia
Interventions: High-Intensity Functional Training, Aerobic and Resistance Training; Other
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Opioid Use Disorder, Sleep Disturbance
Interventions: Wearable bright light therapy device, Wearable placebo light therapy device; Device
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Chronic Kidney Disease, Type 1 Diabetes Mellitus
Interventions: Finerenone, Placebo; Drug · Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 28
States / cities: Surprise, Arizona • Stanford, California • Vallejo, California + 22 more

Conditions: Fatigue
Interventions: Open-label placebo intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Bipolar Disorder
Interventions: Magnetic Resonance Imaging, Psychiatric testing, Eye-Tracking, Neuropsychology Evaluation; Other
Lead sponsor: Jennifer Sweet; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: High Grade Glioma
Interventions: PET-MRI Brain Scan, Blood draw, Memory testing, Optional lumbar puncture for cerebrospinal fluid collection; Procedure · Diagnostic Test · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Athletic Injuries
Interventions: Intervention; Other
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Preeclampsia Severe
Interventions: Nifedipine 30 MG, Placebos; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Esophageal Adenocarcinoma, Esophageal Cancer
Interventions: Standard of care chemotherapy, LNSC; Other · Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Obsessive Compulsive Disorder (OCD)
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 3 Years to 8 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Opioid-Related Disorders, Substance-Related Disorders, Intimate Partner Violence (IPV), Stress Disorders, Post-Traumatic, Domestic Violence, Medication for Opioid Use Disorder (MOUD), Post Traumatic Stress Disorder PTSD
Interventions: Pre-Pilot WINGS++++; Behavioral
Lead sponsor: Dawn A. Goddard-Eckrich; Other
Eligibility: 18 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: New York, New York • Newburgh, New York

Conditions: Insomnia
Interventions: Internet-based Self-help Insomnia Intervention; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Psoriasis, Atopic Dermatitis
Interventions: In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil, Calcipotriene, Tapinarof, Crisaborole, Tacrolimus, Adalimumab, Etanercept, Certolizumab, Infliximab, Secukinumab, Ixekizumab, Apremilast, Risankizumab, Ustekinumab, Hydroxychloroquine, Methotrexate, Mycophenolate, Azathioprine, Chloroquine, Cyclosporine, Tofacitinib, Deucravacitinib, Dupilumab, Tralokinumab, Guselkumab, Tildrakizumab, Baractinib, Abrocitinib, Upadacitinib, Lebrikizumab, Nemolizumab, Ruxolitinib, Bimekizumab, Roflumilast; Device · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Depression
Interventions: Problem Solving Therapy (PST), Medication Management; Behavioral
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lung Cancer
Interventions: Five Psycho-educational Session(s), One Psycho-educational Session(s); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus, Type 2
Interventions: Brief CBT; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Diabetes Mellitus, Type 1
Interventions: Diabetes Assistant (DiAs); Device
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years to 64 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Santa Barbara, California • Charlottesville, Virginia

Conditions: Executive Dysfunction, Cognitive Impairment
Interventions: ASCEND-I; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 30 Years to 89 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 1 Diabetes Mellitus
Interventions: Overnight CLC, Sensor-Augmented Pump Therapy (SAP); Device
Lead sponsor: Sue Brown; Other
Eligibility: 21 Years to 64 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Head and Neck Carcinoma
Interventions: Best Practice, Exercise Intervention, Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Congenital Heart Disease, Neurodevelopment, Executive Function, Working Memory Training, Infant Open-heart Surgery
Interventions: Cogmed Working Memory Training; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prevention
Interventions: Stage 1 Strength Based Case Management (SBCM) Condition, Stage 2 PrEPare for Work Intervention Condition; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 5
States / cities: Los Angeles, California • Providence, Rhode Island

Conditions: Stroke, Spatial Neglect
Interventions: Family-Clinician Collaboration Program; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: West Orange, New Jersey

Search by objective public record fields.

Have Physical Therapists Attitudes and Beliefs Towards Vital Assessment Changed Following the COVID-19 Pandemic?

CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults

Adjunctive Bright Light Therapy for Opioid Use Disorder

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors

Brain Circuitry Analysis in Bipolar Disorder

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

Training for Injury Prevention in Collegiate Soccer Players

Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor

Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma

Family Based Cognitive-Behavioral Treatment for Preschoolers With Obsessive Compulsive Disorder

Pre-Pilot (R61) WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD

Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Improving Depression Treatment for Older Minority Adults

The Transitions Project: Efficacy Trial

Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study

Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy

Cognitive Training in Stroke Rehabilitation

Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes

Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers

Improving Neurodevelopment in Adolescents With Congenital Heart Disease

Optimizing PrEP Uptake and Adherence Among Male Sex Workers

Family-Clinician Collaboration to Improve Neglect and Rehabilitation Outcome After Stroke